You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Naloxone Hydrochloride And Pentazocine Hydrochloride patents expire, and when can generic versions of Naloxone Hydrochloride And Pentazocine Hydrochloride launch?

Naloxone Hydrochloride And Pentazocine Hydrochloride is a drug marketed by Lupin, Sun Pharm Inds Ltd, and Watson Labs. and is included in three NDAs.

The generic ingredient in NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Naloxone Hydrochloride And Pentazocine Hydrochloride

A generic version of NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE was approved as naloxone hydrochloride; pentazocine hydrochloride by WATSON LABS on January 21st, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE?
  • What are the global sales for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE?
  • What is Average Wholesale Price for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE?
Summary for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
Drug patent expirations by year for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
Recent Clinical Trials for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Center for Advancing Translational Science (NCATS)Phase 1
University of WashingtonPhase 1
National Institute on Aging (NIA)Phase 1

See all NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE clinical trials

Pharmacology for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

US Patents and Regulatory Information for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE naloxone hydrochloride; pentazocine hydrochloride TABLET;ORAL 075735-001 Jul 11, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Ltd NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE naloxone hydrochloride; pentazocine hydrochloride TABLET;ORAL 075523-001 Mar 17, 2000 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE naloxone hydrochloride; pentazocine hydrochloride TABLET;ORAL 074736-001 Jan 21, 1997 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.